Navigation Links
Thalidomide Added to Standard Therapy Prolongs Overall Survival in Newly Diagnosed Multiple Myeloma Patients Over Age 75
Date:12/9/2007

neuropathy, neutropenia, and depression were observed in the MP-T arm of the study, no significant differences in rates of deep venous thrombosis or somnolence were found between the treatment arms. Toxicities in the MP-T arm were considered acceptable in this very elderly population.

"While the MP-T treatment regimen has become a standard treatment for newly diagnosed patients with multiple myeloma up to 75 years of age, those older than 75 represent more than 20 percent of myeloma patients, and are frequently excluded from large-scale clinical trials," said Cyrille Hulin, M.D., on behalf of the Intergroupe Francophone du Myelome and a principal investigator of the trial. "These are the first data to demonstrate the therapeutic benefit of the addition of thalidomide to MP for patients over age 75, which together with other recent data, demonstrate that MP-T therapy should become the reference treatment for all patients older than 65 years with newly-diagnosed multiple myeloma."

Pharmion submitted an application to the European Medicines Agency (EMEA) in January 2007 for a marketing authorization application for Thalidomide Pharmion in combination with melphalan and prednisone as first line treatment of patients with untreated multiple myeloma, aged 65 years or older or ineligible for high dose chemotherapy.

Thalidomide Data at ASH

Date / Time / Location: December 9, 2007; 4:30-6:00 p.m.; Rooms C303-C305, Georgia World Congress Center
Session: Myeloma: Firstline Phase III Trials in Multiple Myeloma

-- Oral Presentation - 4:30 p.m.: Velcade-Thalidomide-Dexamethasone (VTD)

vs Thalidomide-Dexamethasone (TD) in Preparation for Autologous Stem-

Cell Transplantation (ASCT) in Newly Diagnosed Multiple Myeloma

(Abstract #73).

-- Oral Presentation - 5:00 p.m.: Melphalan-Prednisone-Thalidomide (MP-T)

Demonstrates a Significant Survival Advantage in Elderly Patients .75

years wi
'/>"/>

SOURCE Pharmion Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Thalidomide Improves Outcomes for Older Myeloma Patients
2. Corals added to IUCN Red List of Threatened Species for first time
3. Halozyme Therapeutics Added to Nasdaq Biotech Index
4. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
5. Standard Management Announces OTCBB Listing
6. Gastroenterology sets standards for CT colonography
7. Public Health and Need for Consistent Standards Preclude Exception for Breastfeeding Mother in National Medical Licensing Test
8. New Drug No Substitute for Standard Blood-Clot Therapy
9. National Quality Forum Issues First Consensus Standards for the Treatment of Substance Use Conditions
10. New guidelines set to improve standard of cows milk allergy care
11. Green Seal Ramps Up Environmental Standard for Household Cleaners
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... The need ... In an effort to provide comfort to patients as well as visiting friends and ... solution: free phone charging stations. , The stations - powered by ChargeItSpot , ...
(Date:7/30/2015)... ... July 30, 2015 , ... Ross A. Clevens, MD, FACS has ... Professor of Plastic Surgery. This is Dr. Clevens’ second appointment by the prestigious ... university, developing a strong presence and a valuable mentoring program for medical students. ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... the latest issue of Inclusive™ magazine, its multimedia publication focused on implant dentistry, ... of the new issue, Volume 6, Issue 2, as well as past issues ...
(Date:7/30/2015)... ... July 30, 2015 , ... Boston ... the annual All-Stars Summit. Google Partners is the platform for search marketing agencies ... full support and tools necessary to run successful search marketing campaigns. Google Partners ...
(Date:7/30/2015)... Wisconsin (PRWEB) , ... July 30, 2015 , ... Quintessa ... Kybella is a nonsurgical treatment designed specifically for the elimination of ... one of the first locations in the state of Wisconsin to offer this innovative ...
Breaking Medicine News(10 mins):Health News:Hospitals Add Phone Charging Stations as an Amenity for Patients and Visitors 2Health News:Leading Melbourne Facial Plastic Surgeon Reappointed by UCF 2Health News:Leading Melbourne Facial Plastic Surgeon Reappointed by UCF 3Health News:Glidewell Laboratories Puts Out Latest Issue of Dental Implant Magazine Inclusive™ 2Health News:Glidewell Laboratories Puts Out Latest Issue of Dental Implant Magazine Inclusive™ 3Health News:Glidewell Laboratories Puts Out Latest Issue of Dental Implant Magazine Inclusive™ 4Health News:Boston Web Marketing Attends Google Partners All-Stars Summit 2Health News:Quintessa MedSpa Offers Nonsurgical Double-chin Elimination 2
... Experts agree that long-term alcohol abuse is detrimental to ... to a study published in Age and Ageing ... that light-to-moderate alcohol consumption may decrease the risk of ... studies have suggested the prevalence of alcohol-related dementia to ...
... By Amanda Gardner HealthDay Reporter , TUESDAY, March 1 ... announcement Monday that researchers reconfigured immune cells so that they became ... But they say the jury is out on whether the ... is ultimately a cure or what,s called a "functional cure" -- ...
... The National Eye Institute (NEI) and Food and Drug ... functional vision-related endpoints for clinical trials of visual prostheses ... visual acuity, visual fields and contrast sensitivity. These assessments ... test outcomes. Today, functional vision outcomes ...
... Reporter , TUESDAY, March 1 (HealthDay News) -- Half of ... new health care reform law that requires all Americans not ... support it, a new Harris Interactive/HealthDay poll finds. ... seem to sway opinion back toward support for it. ...
... March 1, 2011 The American Sociological Association (ASA) ... dedicated to research on the sociology of mental health ... Health (SMH) journal features original, peer-reviewed studies that ... the social origins of mental health and illness, the ...
... Ohio New research has identified a small subset of ... to a rare incurable form of leukemia. The study, ... Center Arthur G. James Cancer Hospital and Richard J. ... lymphocyte leukemia can occur in a small subset of white ...
Cached Medicine News:Health News:Research suggests alcohol consumption helps stave off dementia 2Health News:Research suggests alcohol consumption helps stave off dementia 3Health News:Gene Therapy Against HIV Not a Proven Cure, Experts Say 2Health News:Gene Therapy Against HIV Not a Proven Cure, Experts Say 3Health News:Gene Therapy Against HIV Not a Proven Cure, Experts Say 4Health News:Visual prostheses: Symposium to explore combining functional endpoints 2Health News:Few Support 'Individual Mandate' in Health Care Reform Law, Poll Finds 2Health News:Few Support 'Individual Mandate' in Health Care Reform Law, Poll Finds 3Health News:Few Support 'Individual Mandate' in Health Care Reform Law, Poll Finds 4Health News:ASA launches new journal focused on mental health and illness 2Health News:A small subset of normal white blood cells gives rise to a rare leukemia, study shows 2
(Date:7/30/2015)... PTC Therapeutics, Inc. (NASDAQ: PTCT ) ... for the second quarter ending June 30, 2015. ... the organization.  We are excited to be near the ... ever conducted with topline results expected in the fourth ... PTC Therapeutics, Inc. "Translarna is now commercially available in ...
(Date:7/30/2015)... , July 30, 2015 Tianyin Pharmaceutical ... pharmaceutical company that specializes in the patented biopharmaceutical, modernized ... ingredients (API), provided updates regarding the notice it received ... (the "Exchange") indicating that the Company was below certain ... in Sections 134 and 1101 of the NYSE MKT ...
(Date:7/30/2015)... , July 30, 2015 Eisai Inc. announced ... the United States , European Union and ... and MHLW, respectively) for eribulin, for the treatment of ... received prior chemotherapy for advanced or metastatic disease. ... from a pivotal global Phase 3 clinical trial (Study ...
Breaking Medicine Technology:PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 10TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 3Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 4Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 5
... University of Alabama at Birmingham (UAB) Health System became ... to utilize intrafraction motion review (IMR), or "triggered imaging," ... cancer.  IMR, which is a unique capability of the ... VAR ) enables visual verification that a tumor ...
... N.J., Nov. 21, 2011  Omthera Pharmaceuticals, Inc., a ... Jerry Wisler, President and Chief Executive Officer, will ... Piper Jaffray Health Care Conference on Wednesday, November ... York Palace hotel. About Omthera ...
Cached Medicine Technology:Clinicians at the University of Alabama at Birmingham (UAB) Health System First in World to Use "Triggered Imaging" Technology From Varian Medical Systems 2Clinicians at the University of Alabama at Birmingham (UAB) Health System First in World to Use "Triggered Imaging" Technology From Varian Medical Systems 3
The Trilogy system builds on the success of the Harris/Galante Porous and HGP II cups by combining proven features with new technology designed to inhibit the formation and migration of polyethylene ...
The Secur-Fit cups incorporate enhancements derived from years of clinical, radiographic, and implant retrieval observations....
The Bofor acetabular revision cup addresses cases of severe acetabular destruction....
The Protract stem offers a press-fit option which will allow choice of standard or lateralized neck offsets while keeping a consistent leg length....
Medicine Products: